Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
MT GENEX, 39% Increase in Ordinary Profit, Record High for The First Time in Fifteen Years
9820 MT GENEX CORPORATION 【J-GAAP】
Earnings ReportMT GENEX CORPORATION <9820> [TSE Std] announced its financial results after the market closed on May 12th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 decreased 4.6% from the previous period to 431 million yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to expand to 38.5% to 597 million yenExpected to reach record high profits for the first time in fifteen years. This will be the fourth consecutive term of revenue growth.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit surged 3.1 times that of the same period last year, reaching 157 million yen. The operating profit margin drastically improved from 5.7% in the same period last year to 12.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 3,263 | 364 | 382 | 241 | 224.5 | 40 | May 12, 2023 | J-GAAP |
| Mar, 2024 | 3,790 | 438 | 452 | 277 | 257.9 | 40 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 3,950 | 410 | 431 | 264 | 246.2 | 40 | May 12, 2025 | J-GAAP |
| YoY | +4.2% | -6.4% | -4.6% | -4.7% | -4.5% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 3,950 | 410 | 431 | 264 | 246.2 | 40 | May 9, 2025 | J-GAAP |
| Mar, 2025 Results | 3,950 | 410 | 431 | 264 | 246.2 | 40 | May 12, 2025 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 1,877 | 179 | 191 | 113 | 105.1 | 0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 1,972 | 119 | 126 | 72 | 66.9 | 0 | May 12, 2025 | J-GAAP |
| YoY | +5.1% | -33.5% | -34.0% | -36.3% | -36.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 3,790 | 438 | 452 | 277 | 257.9 | 40 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 3,950 | 410 | 431 | 264 | 246.2 | 40 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 5,000 | 582 | 597 | 377 | 350.3 | 40 | May 12, 2025 | J-GAAP |
| YoY | +26.6% | +42.0% | +38.5% | +42.8% | +42.3% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 838 | 48 | 50 | 24 | 22.3 | 5.7 | May 13, 2024 | J-GAAP |
| Apr - Jun, 2024 | 856 | 58 | 66 | 34 | 32.3 | 6.8 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 1,021 | 121 | 125 | 79 | 73.5 | 11.9 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 898 | 79 | 83 | 52 | 48.4 | 8.8 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,175 | 152 | 157 | 99 | 92.3 | 12.9 | May 12, 2025 | J-GAAP |
| YoY | +40.2% | +216.7% | +214.0% | +312.5% | +313.2% |
Related Articles
Keio, 9% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 5 yen
NAKANISHI, The Current Fiscal Year Net Income Revised Downward to an Unexpected 2% Decrease
AZ-COM MARUWA , 3% Increase in Ordinary Profit for The Current Fiscal Year
TACHIBANA ELETECH, 8% Decrease in Ordinary Profit for The Current Fiscal Year
SAPPORO CLINICAL LAB, 9% Increase in Ordinary Profit for The Current Fiscal Year
UNIVANCE, 54% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 2 yen
Medical Data Vision, Jan-Mar (1Q) Ordinary Profit Decreases by 9%
PALTAC, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 15 yen
Showa Sangyo, 4% Decrease in Ordinary Profit for The Current Fiscal Year
NAGANO KEIKI , 9% Decrease in Ordinary Profit for The Current Fiscal Year